Extent of bilirubin interference with Beckman creatinine methods

被引:9
作者
Dimeski, Goce [1 ]
McWhinney, Brett [1 ]
Jones, Brock [1 ]
Mason, Rebecca [1 ]
Carter, Andrew [1 ]
机构
[1] Princess Alexandra Hosp, QHPS, Dept Chem Pathol, Woolloongabba, Qld 4102, Australia
关键词
D O I
10.1258/acb.2007.007079
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background: The aim of the study was to determine the extent of bilirubin interference on two different Beckman-Coulter creatinine methods used on the CX5 PRO/DxC 600 and the DxC 800 systems, respectively. Methods: The Beckman methods were compared with a high -performance liquid chromatography (HPLC) method using 104 patient samples with creatinine concentrations < 133 mu mol/L and bilirubin concentrations of between 30 and 802 mu mol/L. Results: The linear regression analysis calculations expressing the relationship between bilirubin concentration and the observed difference between the Beckman and HPLC creatinine methods are: DxC800 creatinine M (modular or cup) method: r(2) 0.217, slope -0.023 and intercept 6.43; and DxC600 method: r(2) 0.7324, slope -0.0882 and intercept 12.01. Conclusions: There is significantly greater interference by bilirubin on the CX5 PRO/DxC 600 method, which can lead to inaccuracy in the calculation of the estimated glomerular filtration rate by the Modification of Diet in Renal Disease equation.
引用
收藏
页码:91 / 92
页数:2
相关论文
共 7 条
[1]
DIMESKI G, 2006, CLIN BIOCH REG, V27, pS42
[2]
INVESTIGATIONS INTO NEGATIVE INTERFERENCE BY JAUNDICED PLASMA IN KINETIC JAFFE METHODS FOR PLASMA CREATININE DETERMINATION [J].
KNAPP, ML ;
HADID, O .
ANNALS OF CLINICAL BIOCHEMISTRY, 1987, 24 :85-97
[3]
Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the National Kidney Disease Education Program [J].
Myers, GL ;
Miller, WG ;
Coresh, J ;
Fleming, J ;
Greenberg, N ;
Greene, T ;
Hostetter, T ;
Levey, AS ;
Panteghini, M ;
Welch, M ;
Eckfeldt, JH .
CLINICAL CHEMISTRY, 2006, 52 (01) :5-18
[4]
Does bilirubin cause interference in Roche creatinine methods? [J].
Owen, Laura J. ;
Keevil, Brian G. .
CLINICAL CHEMISTRY, 2007, 53 (02) :370-371
[5]
VANTSANT P, 1995, CLIN CHEM, V41, P1773
[6]
Yue-Dong Yang, 1998, Biomedical Chromatography, V12, P47, DOI 10.1002/(SICI)1099-0801(199803/04)12:2<47::AID-BMC717>3.0.CO
[7]
2-Y